
Leading international law firm Clifford Chance announced that Sharis Pozen has joined the Firm’s global leadership team.
Pozen is is the co-head of the Firm’s global Antitrust group. She has extensive experience in both government and private practice. Over the course of her career, Pozen has held senior positions at General Electric, the US Department of Justice and the US Federal Trade Commission. She joined the Firm as partner in May 2019.
Pozen now sits on Clifford Chance’s Wider Leadership Group (WLG) which includes the heads of the Firm’s global practice areas, as well as the members of the Firm’s Executive Leadership Group (ELG), Clifford Chance’s top strategic decision-making body.
Matthew Layton, Clifford Chance Managing Partner offers, “Given Sharis’ exceptional legal skills and broad leadership experience, we’re excited to bring her perspectives to our leadership group as we execute our strategy and plan for the future. With her addition, we continue to see the diversity of this group grow. Such a variety of voices and perspectives only strengthens our Firm, and this is equally true at leadership level. I very much look forward to collaborating with Sharis over the coming years.”
The WLG undertakes two formal reviews of the Firm’s strategy each year. Pozen will join these meetings, as well as other relevant ELG sessions, including those hosted by the Americas. She will serve a term of two years.
Pozen has also been appointed to Clifford Chance’s Americas Management Committee, which is responsible for strategic and business planning, operational performance and financial management of the Firm in the Americas region.
Full Content: Clifford Chance
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas